|
?:authorAffiliation
|
-
[\'Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.\', \'Section of Pharmacology \'L. Donatelli\', Department of Experimental Medicine, Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, University of Campania \'Luigi Vanvitelli\', Naples, Italy.\', \'Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.\', \'Sicilian Regional Pharmacovigilance Centre, University Hospital of Messina, Messina, Italy.\', \'Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.\', \'Department of Medical and Surgical Science, Alma Mater Studiorum, University of Bologna, Bologna, Italy.\', \'PeaRL-Perinatal Research Laboratory, NEUROFARBA Department, University of Florence and CiaoLapo Foundation for Perinatal Health, Florence, Italy.\', \'Unit of Adverse Drug Reactions Monitoring, University Hospital of Pisa, Pisa, Italy.\', \'Immunology Unit, University Hospital, Verona, Italy.\', \'Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy. gianluca.trifiro@univr.it.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}